| First Author | Becares N | Year | 2019 |
| Journal | Cell Rep | Volume | 26 |
| Issue | 4 | Pages | 984-995.e6 |
| PubMed ID | 30673619 | Mgi Jnum | J:282699 |
| Mgi Id | MGI:6380941 | Doi | 10.1016/j.celrep.2018.12.094 |
| Citation | Becares N, et al. (2019) Impaired LXRalpha Phosphorylation Attenuates Progression of Fatty Liver Disease. Cell Rep 26(4):984-995.e6 |
| abstractText | Non-alcoholic fatty liver disease (NAFLD) is a very common indication for liver transplantation. How fat-rich diets promote progression from fatty liver to more damaging inflammatory and fibrotic stages is poorly understood. Here, we show that disrupting phosphorylation at Ser196 (S196A) in the liver X receptor alpha (LXRalpha, NR1H3) retards NAFLD progression in mice on a high-fat-high-cholesterol diet. Mechanistically, this is explained by key histone acetylation (H3K27) and transcriptional changes in pro-fibrotic and pro-inflammatory genes. Furthermore, S196A-LXRalpha expression reveals the regulation of novel diet-specific LXRalpha-responsive genes, including the induction of Ces1f, implicated in the breakdown of hepatic lipids. This involves induced H3K27 acetylation and altered LXR and TBLR1 cofactor occupancy at the Ces1f gene in S196A fatty livers. Overall, impaired Ser196-LXRalpha phosphorylation acts as a novel nutritional molecular sensor that profoundly alters the hepatic H3K27 acetylome and transcriptome during NAFLD progression placing LXRalpha phosphorylation as an alternative anti-inflammatory or anti-fibrotic therapeutic target. |
